Research catches up to world's fastest-growing plant
Salk researchers discover that miniature aquatic plant provides insight into genome design principles that could enable development of next-generation crops
2021-02-01
(Press-News.org) LA JOLLA--(February 1, 2021) Wolffia, also known as duckweed, is the fastest-growing plant known, but the genetics underlying this strange little plant's success have long been a mystery to scientists. Now, thanks to advances in genome sequencing, researchers are learning what makes this plant unique--and, in the process, discovering some fundamental principles of plant biology and growth.
A multi-investigator effort led by scientists from the Salk Institute is reporting new findings about the plant's genome that explain how it's able to grow so fast. The research, published in the February 2021 issue of Genome Research, will help scientists to understand how plants make trade-offs between growth and other functions, such as putting down roots and defending themselves from pests. This research has implications for designing entirely new plants that are optimized for specific functions, such as increased carbon storage to help address climate change.
"A lot of advancement in science has been made thanks to organisms that are really simple, like yeast, bacteria and worms," says Todd Michael, first author of the paper and a research professor in Salk's Plant Molecular and Cellular Biology Laboratory. "The idea here is that we can use an absolutely minimal plant like Wolffia to understand the fundamental workings of what makes a plant a plant."
Wolffia, which is found growing in fresh water on every continent except Antarctica, looks like tiny floating green seeds, with each plant only the size of a pinhead. It has no roots and only a single fused stem-leaf structure called a frond. It reproduces similar to yeast, when a daughter plant buds off from the mother. With a doubling time of as little as a day, some experts believe Wolffia could become an important source of protein for feeding Earth's growing population. (It's already eaten in parts of Southeast Asia, where it's known as khai-nam, which translates as "water eggs.")
To understand what adaptations in Wolffia's genome account for its rapid growth, the researchers grew the plants under light/dark cycles, then analyzed them to determine which genes were active at different times of the day. (Most plants' growth is regulated by the light and dark cycle, with the majority of growth taking place in the morning.)
"Surprisingly, Wolffia only has half the number of genes that are regulated by light/dark cycles compared to other plants," Michael says. "We think this is why it grows so fast. It doesn't have the regulations that limit when it can grow."
The researchers also found that genes associated with other important elements of behavior in plants, such as defense mechanisms and root growth, are not present. "This plant has shed most of the genes that it doesn't need," Michael adds. "It seems to have evolved to focus only on uncontrolled, fast growth."
"Data about the Wolffia genome can provide important insight into the interplay between how plants develop their body plan and how they grow," says HHMI Investigator and Professor Joseph Ecker, who is also director of Salk's Genomic Analysis Laboratory and a coauthor of the paper. "This plant holds promise for becoming a new lab model for studying the central characteristics of plant behavior, including how genes contribute to different biological activities."
One focus of Michael's lab is learning how to develop new plants from the ground up, so that they can be optimized for certain behaviors. The current study expands knowledge of basic plant biology as well as offers the potential for improving crops and agriculture. By making plants better able to store carbon from the atmosphere in their roots, an approach pioneered by Salk's Harnessing Plants Initiative, scientists can optimize plants to help address the threat of climate change.
Michael plans to continue studying Wolffia to learn more about the genomic architecture of plant development by using this simplified plant to understand the networks that control fate.
INFORMATION:
Other authors on the study were Nolan Hartwick, Florian Jupe and Justin P. Sandoval of Salk; Evan Ernst and Robert A. Martienssen of Cold Spring Harbor Laboratory; Philomena Chu, Sarah Gilbert, and Eric Lam of Rutgers, The State University of New Jersey; Douglas Bryant and Todd C. Mockler of Donald Danforth Plant Science Center; Stefan Ortleb, Joerg Fuchs, and Ljudmylla Borisjuk of Leibniz Institute of Plant Genetics and Crop Plant Research in Germany; Erin L. Baggs and Ksenia V. Krasileva of the University of California, Berkeley; K. Sowjanya Sree of Central University of Kerala, in India; and Klaus J. Appenroth of Friedrich Schiller University of Jena, in Germany.
This work was funded by the US Department of Energy, Office of Science, Office of Biological and Environmental Research program. It was also supported by a grant from the Hatch project from the New Jersey Agricultural Experiment Station at Rutgers University and the Howard Hughes Medical Institute.
About the Salk Institute for Biological Studies:
Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin. Learn more at: END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-01
DALLAS, Feb. 1, 2021 -- Women with a history of diabetes during pregnancy (gestational diabetes) are twice as likely by mid-life to develop calcium in heart arteries - a strong predictor of heart disease - even if healthy blood sugar levels were attained many years after pregnancy, according to new research published today in the American Heart Association's flagship journal Circulation.
Gestational diabetes, which is high blood sugar levels (glucose intolerance) first recognized during pregnancy, affects approximately 9% of U.S. pregnancies and up to 20% worldwide. After pregnancy, women who had gestational diabetes are at higher risk of developing prediabetes or Type 2 diabetes, conditions that are risk factors ...
2021-02-01
Irvine, Calif. -- Researchers from the University of California, Irvine and the University of Minnesota have found that an enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin. They also discovered that duloxetine, an antidepressant that boosts serotonin levels, could be an alternative to opioids in treating chronic pain.
"Finding safe and effective alternatives to opioids is a research priority, especially for patients with sickle cell disease," said Dr. Keith Hoots, director of the Division of Blood Diseases and Resources at the National Heart, Lung, and Blood Institute. "It's encouraging to see a dose-response relationship to nutrients and companions in mice, ...
2021-02-01
ROCHESTER, Minn. -- Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient's heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient's QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.
The heart beats by a complex system of electrical signals triggering regular and necessary contractions. Clinicians evaluate the heart's rate-corrected QT interval, or QTc, as a vital ...
2021-02-01
An underused type of knee surgery in younger patients, called high tibial osteotomy, shows considerable success in reducing the need for total knee replacement, according to new research in CMAJ (Canadian Medical Association Journal).
"High tibial osteotomy is a knee surgery aimed at younger patients in the earlier stages of knee osteoarthritis. One of its goals is to prevent or delay the need for knee replacement," says coauthor Dr. Trevor Birmingham, Canada Research Chair in the Faculty of Health Sciences and the Bone and Joint Institute at Western University, London, Ontario. "In some ways, it's like performing ...
2021-02-01
A calculation so complex that it takes twenty years to complete on a powerful desktop computer can now be done in one hour on a regular laptop. Physicist Andreas Ekström at Chalmers University of Technology, together with international research colleagues, has designed a new method to calculate the properties of atomic nuclei incredibly quickly.
The new approach is based on a concept called emulation, where an approximate calculation replaces a complete and more complex calculation. Although the researchers are taking a shortcut, the solution ends up almost exactly the same. It is reminiscent of algorithms ...
2021-02-01
February 1, 2021 - Researchers have identified another good reason to eat more mushrooms. New research , published in Food Science & Nutrition (January 2021) found that adding a mushroom serving to the diet increased the intake of several micronutrients, including shortfall nutrients such as vitamin D, without any increase in calories, sodium or fat.
Dr. Victor L. Fulgoni III and Dr. Sanjiv Agarwal modeled the addition of mushrooms to National Health and Nutrition Examination Survey (NHANES) 2011-2016 dietary data looking at a composite of white, crimini and portabella mushrooms at a 1:1:1 ratio; one scenario including UV-light exposed mushrooms; and one scenario including oyster mushrooms ...
2021-02-01
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal PLOS ONE.
Identifying ...
2021-01-31
(Singapore--January 31, 2021 2:40 p.m. SPT 1:40 a.m. EST)--Patient-reported outcomes from the phase III CROWN study showed that time to treatment deterioration (TTD) in pain in chest, dyspnea, and cough was comparable between those who received lorlatinib and patients who took crizotinib. The research was presented today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer Singapore.
Lorlatinib, a third-generation ALK inhibitor, significantly improved progression-free survival compared to crizotinib in ...
2021-01-31
COVID-19 mortality racial disparities in the U.S. are associated with social factors like income, education and internet access, according to a Rutgers study.
The study, published in the Journal of Racial and Ethnic Health Disparities, highlights the need for public health policies that address structural racism.
The researchers investigated the association between COVID-19 cases and deaths in 2,026 U.S. counties from January to October 2020 and social determinants of health, which can raise the risk for infection and death.
They also looked at factors known or thought to impact COVID-19 outcomes, including the counties' population density, days since the first COVID-19 death and percent of residents who are over age 65, are smokers or who have chronic diseases such as obesity, ...
2021-01-30
CHICAGO (January 30, 2021) -- Select patients born with heart defects and who undergo congenital heart surgery recover with few complications and reduced opioid use when a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program is used, according to research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
"We have embarked on a new paradigm for patient care with the goal of improving recovery, patient experience, and the value of care that we provide," said Nathalie Roy, MD, from Boston Children's Hospital in Massachusetts. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Research catches up to world's fastest-growing plant
Salk researchers discover that miniature aquatic plant provides insight into genome design principles that could enable development of next-generation crops